ACB Key Statistics, Chart & Performance
The current stock price of ACB is 4.365 USD. In the past month the price decreased by -1.56%. In the past year, price increased by 21.1%.
ACB Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ACB. When comparing the yearly performance of all stocks, ACB turns out to be only a medium performer in the overall market: it outperformed 53.96% of all stocks.
ACB Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACB. ACB may be in some trouble as it scores bad on both profitability and health.
ACB Financial Highlights
Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS increased by 57.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.78% | ||
| ROE | -11.07% | ||
| Debt/Equity | 0.07 |
ACB Forecast & Estimates
9 analysts have analysed ACB and the average price target is 5.73 USD. This implies a price increase of 31.16% is expected in the next year compared to the current price of 4.365.
For the next year, analysts expect an EPS growth of -1574.6% and a revenue growth 11.1% for ACB
ACB Ownership
About ACB
Company Profile
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Company Info
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T5J 1Y6 CA
CEO: Terry Booth
Employees: 1101
Phone: 16043625207
AURORA CANNABIS INC / ACB FAQ
Can you describe the business of AURORA CANNABIS INC?
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
What is the stock price of AURORA CANNABIS INC today?
The current stock price of ACB is 4.365 USD. The price decreased by -1.24% in the last trading session.
Does ACB stock pay dividends?
ACB does not pay a dividend.
What is the ChartMill rating of AURORA CANNABIS INC stock?
ACB has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is AURORA CANNABIS INC (ACB) stock traded?
ACB stock is listed on the Nasdaq exchange.
What is the analyst forecast for ACB stock?
9 analysts have analysed ACB and the average price target is 5.73 USD. This implies a price increase of 31.16% is expected in the next year compared to the current price of 4.365.
What is the Short Interest ratio of AURORA CANNABIS INC (ACB) stock?
The outstanding short interest for AURORA CANNABIS INC (ACB) is 12.84% of its float.